NCT03951025View on ClinicalTrials.gov

Study of the Bioavailability of a Food Supplement Rich in Melatonin Administered Sublingually and Orally (MELATONIN)

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

June 5, 2019

Primary Completion Date

August 7, 2019

Study Completion Date

August 7, 2019

Conditions
Biological Availability
Interventions
DIETARY_SUPPLEMENT

Melatonin oral administration

One tablet with1 mg of melatonin and 82 mg of excipients

DIETARY_SUPPLEMENT

Melatonin sublingual administration

One tablet with 1 mg of melatonin and 82 mg of excipients

Trial Locations (1)

Unknown

Centro Tecnológico de Nutrición y Salud (Eurecat-Reus), Reus

All Listed Sponsors
collaborator

Fundació Eurecat

OTHER

collaborator

Hospital Universitari Sant Joan de Reus

OTHER

collaborator

Plantas Medicinales y Complementos Alimenticios (PLAMECA), S.A.

UNKNOWN

collaborator

University Rovira i Virgili

OTHER

lead

Technological Centre of Nutrition and Health, Spain

OTHER

NCT03951025 - Study of the Bioavailability of a Food Supplement Rich in Melatonin Administered Sublingually and Orally (MELATONIN) | Biotech Hunter | Biotech Hunter